Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients

被引:0
|
作者
Luo, M. [1 ]
Liu, R. -Z. [2 ]
Li, Y. -J. [3 ]
Zhang, S. -D. [3 ]
Wu, Z. -Y. [3 ]
机构
[1] Henan Univ, Sch Clin Med, Kaifeng, Peoples R China
[2] Henan Univ Peoples Hosp, Henan Prov Peoples Hosp, Zhengzhou, Peoples R China
[3] Luohe First Peoples Hosp, Luohe, Peoples R China
关键词
Disulfidptosis; Lung adenocarcinoma; Prognosis; TME; CELL-DEATH; CANCER; GLUTAMATE; FERROPTOSIS; MECHANISMS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
- OBJECTIVE: Disulfidptosis is a novel mode of cell death, a programmed mode of intracellular disulfide accumulation due to solute carrier family 7 member 11 (SLC7A11)-mediated abnormalities in the cell membrane cystine trans-port system. Numerous studies have confirmed the prominent role played by SLC7A11 in tumors, but the involvement of SLC7A11 as an important mediator of disulfidptosis in the death process of lung adenocarcinoma cells remains unclear. MATERIALS AND METHODS: We obtained 4,107 SLC7A11-related genes and analyzed them using a total of 1,040 lung adenocarcinoma tran-scriptome sequencing data from The Cancer Genome Atlas (TCGA) cohort and GEO (Gene Expression Omnibus) cohort and 991 relevant clinical data. First, we screened for differential genes and identified molecular subtypes for as-sessing characteristic differences between lung adenocarcinoma subtypes under the influence of SLC7A11-associated genes. Then, risk score models were constructed to assess the prog-nosis, immune infiltration, tumor microenviron-ment, and drug treatment effects in lung ade-nocarcinoma patients. Finally, we also analyzed the distribution of cell types and expression of characteristic genes within the tumor using a single-cell database. In addition, relevant drug sensitivities were predicted. RESULTS: We screened 956 genes with signif-icant differences and identified 2 molecular sub-types and found significant differences in their prognosis and that subtype B had a significantly better survival prognosis than subtype A. In ad-dition, we found that pathways associated with cell proliferation division and DNA repair were enriched in the high-risk type A samples. Final-ly, we constructed a robust risk-scoring system, and our risk analysis revealed a general reduc-tion of various immune cell components and tu-mor stromal components in the immune micro -environment of high-risk lung adenocarcinoma and a distinct immune infiltration pattern of im-mune cells, which was associated with a lower survival rate.CONCLUSIONS: Our comprehensive analy-sis of SLC7A11-related genes suggests that di-sulfidptosis has a potential value in the tumor microenvironment, immunity, clinical outcome, and prognosis of lung adenocarcinoma. These findings may increase our understanding of di-sulfidptosis as a novel cell death paradigm and provide ideas for assessing the prognosis of lung adenocarcinoma and developing new diag-nostic and therapeutic strategies.
引用
收藏
页码:9569 / 9585
页数:17
相关论文
共 50 条
  • [31] A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma
    Song, Zipei
    Cao, Xincen
    Wang, Xiaokun
    Li, Yuting
    Zhang, Weiran
    Wang, Yuheng
    Chen, Liang
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [32] Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis
    Zhao, Fangchao
    Su, Lei
    Wang, Xuefeng
    Luan, Jiusong
    Zhang, Xin
    Li, Yishuai
    Li, Shujun
    Hu, Ling
    CLINICAL EPIGENETICS, 2024, 16 (01)
  • [33] A novel disulfidptosis-related gene signature predicts overall survival of glioblastoma patients
    Zhang, Yuxia
    Liu, Bing
    Zhou, Yuelian
    FUTURE SCIENCE OA, 2024, 10 (01):
  • [34] Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma
    Sun, Zhou
    Wang, Jie
    Fan, Zheqi
    Yang, Yongjin
    Meng, Xiangdi
    Ma, Zhaosen
    Niu, Jiqiang
    Guo, Rui
    Tran, Lisa Jia
    Zhang, Jing
    Jiang, Tianxiao
    Liu, Yunfei
    Yang, Qiwei
    Ma, Baoluo
    JOURNAL OF GENE MEDICINE, 2024, 26 (01):
  • [35] Identification of a disulfidptosis-related prognostic signature for prediction of the effect of treatment in patients with endometrial carcinoma
    Peng, Lu
    Gao, Yuan
    Cao, Zifeng
    Pang, Yingxin
    CANCER INNOVATION, 2024, 3 (03):
  • [36] Identification of disulfidptosis-related subtypes in gastric cancer and GAMT is a key gene during disulfidptosis
    Wu, Wenxue
    Tao, Guoqiang
    Chen, Zhiqing
    Zhou, Qi
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [37] Hub gene of disulfidptosis-related immune checkpoints in breast cancer
    Ye Wang
    Yinmei Deng
    Hui Xie
    Sujuan Cao
    Medical Oncology, 40
  • [38] Crosstalk among disulfidptosis-related lncRNAs in lung adenocarcinoma reveals a correlation with immune profile and clinical prognosis
    Liu, Shifeng
    Wang, Song
    Guo, Jian
    Wang, Congxiao
    Zhang, Hao
    Lin, Dongliang
    Wang, Yuanyong
    Hu, Xiaokun
    NON-CODING RNA RESEARCH, 2024, 9 (03): : 772 - 781
  • [39] Prognostic and immune infiltration features of disulfidptosis-related subtypes in breast cancer
    Chen, Sheng
    Li, Xiangrong
    Ao, Wen
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [40] Construction of a Novel Disulfidptosis-Related lncRNA Prognostic Signature in Pancreatic Cancer
    Xing, Faliang
    Qin, Yi
    Xu, Jin
    Wang, Wei
    Zhang, Bo
    MOLECULAR BIOTECHNOLOGY, 2024, 66 (09) : 2396 - 2414